{"id":13889,"date":"2024-11-14T10:51:03","date_gmt":"2024-11-14T18:51:03","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13889"},"modified":"2024-11-14T10:51:03","modified_gmt":"2024-11-14T18:51:03","slug":"semaglutide-shows-potential-in-reducing-alcohol-misuse","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/semaglutide-shows-potential-in-reducing-alcohol-misuse\/","title":{"rendered":"Semaglutide shows potential in reducing alcohol misuse"},"content":{"rendered":"<section class=\"kc-elm kc-css-66944 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-456325 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-606525 kc_text_block\"><p class=\"MsoNormal\" style=\"line-height: 18.75pt;\">Research found the GLP-1 drug semaglutide was associated with reduced hospitalizations and lower suicide risk among people with alcohol use disorder. The study in <a href=\"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2825650#google_vignette\">JAMA Psychiatry<\/a>, based on data for nearly 228,000 people in Sweden, found fewer hospitals with liraglutide as well.<\/p>\n<p class=\"MsoNormal\" style=\"line-height: 18.75pt;\">\u00a0Full Story: <a href=\"https:\/\/www.healthday.com\/health-news\/mental-health\/ozempic-could-help-curb-alcoholism\">HealthDay News<\/a> (11\/13)\u00a0\u00a0<\/p>\n<p class=\"MsoNormal\" style=\"line-height: 18.75pt;\"><span style=\"font-style: inherit;\">\u00a0\u00a0<\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p><span style=\"font-style: inherit;\">\u00a0<\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section><!-- \/wp:post-content -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13889","post","type-post","status-publish","format-standard","hentry","category-diabetes-related-news"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13889"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13889\/revisions"}],"predecessor-version":[{"id":13890,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13889\/revisions\/13890"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}